Literature DB >> 8090222

A brain-specific activator of cyclin-dependent kinase 5.

J Lew1, Q Q Huang, Z Qi, R J Winkfein, R Aebersold, T Hunt, J H Wang.   

Abstract

Phosphorylation of the neurofilament proteins of high and medium relative molecular mass, as well as of the Alzheimer's tau protein, is thought to be catalysed by a protein kinase with Cdc2-like substrate specificity. We have purified a novel Cdc2-like kinase from bovine brain capable of phosphorylating both the neurofilament proteins and tau. The purified enzyme is a heterodimer of cyclin-dependent kinase 5 (Cdk5) and a novel regulatory subunit, p25 (ref. 8). When overexpressed and purified from Escherichia coli, p25 can activate Cdk5 in vitro. Unlike Cdk5, which is ubiquitously expressed in human tissue, the p25 transcript is expressed only in brain. A full-length complementary DNA clone showed that p25 is a truncated form of a larger protein precursor, p35, which seems to be the predominant form of the protein in crude brain extract. Cdk5/p35 is the first example of a Cdc2-like kinase with neuronal function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8090222     DOI: 10.1038/371423a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  165 in total

1.  The Cdk5-p35 kinase associates with the Golgi apparatus and regulates membrane traffic.

Authors:  G Paglini; L Peris; J Diez-Guerra; S Quiroga; A Cáceres
Journal:  EMBO Rep       Date:  2001-11-21       Impact factor: 8.807

2.  Regulation of tau pathology by the microglial fractalkine receptor.

Authors:  Kiran Bhaskar; Megan Konerth; Olga N Kokiko-Cochran; Astrid Cardona; Richard M Ransohoff; Bruce T Lamb
Journal:  Neuron       Date:  2010-10-06       Impact factor: 17.173

3.  Integrin alpha(1) beta(1)-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation.

Authors:  B S Li; L Zhang; J Gu; N D Amin; H C Pant
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

4.  Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4.

Authors:  Luis M Schang; Andrew Bantly; Priscilla A Schaffer
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 5.  Cycling or not cycling: cell cycle regulatory molecules and adult neurogenesis.

Authors:  Pierre Beukelaers; Renaud Vandenbosch; Nicolas Caron; Laurent Nguyen; Gustave Moonen; Brigitte Malgrange
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

6.  Cyclin E constrains Cdk5 activity to regulate synaptic plasticity and memory formation.

Authors:  Junko Odajima; Zachary P Wills; Yasmine M Ndassa; Miho Terunuma; Karla Kretschmannova; Tarek Z Deeb; Yan Geng; Sylwia Gawrzak; Isabel M Quadros; Jennifer Newman; Manjusri Das; Marie E Jecrois; Qunyan Yu; Na Li; Frederic Bienvenu; Stephen J Moss; Michael E Greenberg; Jarrod A Marto; Piotr Sicinski
Journal:  Dev Cell       Date:  2011-09-22       Impact factor: 12.270

7.  The tumor suppressor FBW7 controls ciliary length.

Authors:  Anna S Nikonova; Erica A Golemis
Journal:  EMBO J       Date:  2015-08-12       Impact factor: 11.598

8.  Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy.

Authors:  Nimrod Miller; Zhihua Feng; Brittany M Edens; Ben Yang; Han Shi; Christie C Sze; Benjamin Taige Hong; Susan C Su; Jorge A Cantu; Jacek Topczewski; Thomas O Crawford; Chien-Ping Ko; Charlotte J Sumner; Long Ma; Yong-Chao Ma
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

Review 9.  Striatal glutamatergic mechanisms and extrapyramidal movement disorders.

Authors:  Thomas N Chase; Francesco Bibbiani; Justin D Oh
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  Cyclin dependent kinase 5 is required for the normal development of oligodendrocytes and myelin formation.

Authors:  Yan Yang; Haibo Wang; Jie Zhang; Fucheng Luo; Karl Herrup; James A Bibb; Richard Lu; Robert H Miller
Journal:  Dev Biol       Date:  2013-04-10       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.